Home
INVESTORS
Visionary Leadership. Proven Expertise. Global Impact.
Our team blends clinical insight, commercialization experience, and scientific innovation to quantify muscular perfusion and advance safer orthopedic traumatology. From trauma surgeons to NASA scientists, we're united by one mission: making the invisible visible through Quadplex Ultrasound™ technology.
John Nguyen
Chief Executive Officer
Founder of TraumaPulse Biosystems and architect of Quadplex Ultrasound™, John brings visionary strategy to medtech innovation. His expertise spans brand architecture, regulatory pathways, and investor-grade storytelling, with a proven track record building modular, defensible diagnostic platforms.
As former CEO of Aspire Medical, John led strategic pivots into trauma and neuro diagnostics, establishing the foundation for muscular perfusion quantification. He combines deep technical knowledge with commercial acumen to advance safer orthopedic traumatology worldwide.
Expert Clinical Leadership
Chief Medical Officer
Trauma and orthopedic surgeon with decades of frontline experience in Acute Compartment Syndrome diagnosis and emergency surgical decision-making.
  • Clinical expertise in ACS management
  • Champion of non-invasive diagnostics
  • Patient safety advocate
Chief Regulatory Officer
Veteran navigator of FDA 510(k) and CE Mark pathways with deep expertise in Software as a Medical Device (SaMD) clearance and quality management systems.
  • Global regulatory compliance
  • SaMD clearance specialist
  • Quality systems architect
Chief Technology Officer
Biophysics & IP Commercialization Specialist
Our CTO architects the future of muscular perfusion monitoring through AI-driven ultrasound algorithms and compliance/micromotion sensing technology. With deep expertise in biophysics and intellectual property strategy, they've built hardware-agnostic platforms designed for scalability.
Their vision enables TraumaPulse to partner with multiple OEM manufacturers, expanding our reach across orthopedic traumatology trials (RUO), broader healthcare research, and clinical screening applications. This modular approach creates defensible competitive advantages while accelerating global adoption.
World-Class Scientific Advisors
Former NASA Scientist
Pioneer in microgravity-related perfusion research with 270+ publications in physiology and imaging. Their groundbreaking work in extreme environments informs our approach to muscular perfusion quantification.
Ultrasound Innovator
Recognized leader with 40+ patents in transducer design and imaging pathways. Their expertise in ultrasonic technology drives the precision and reliability of Quadplex Ultrasound™.
Clinical & Strategic Advisors
Clinical Advisory Board
Key opinion leaders (KOLs) across trauma, orthopedics, and emergency medicine provide frontline validation for our technology.
  • ACS diagnosis specialists
  • Emergency medicine physicians
  • Orthopedic trauma surgeons
  • Hospital system directors
Strategic Advisory Board
Medtech entrepreneurs and healthcare innovation leaders guide our commercialization strategy and global expansion.
  • Successful medtech exits
  • Healthcare investment expertise
  • Global market strategists
  • OEM partnership architects
Why Our Team Matters
01
Clinical Credibility
Frontline physicians ensure our muscular perfusion technology solves real-world diagnostic challenges in trauma care and orthopedic surgery.
02
Scientific Depth
NASA-derived innovation and ultrasound expertise create defensible intellectual property that anchors competitive advantage.
03
Commercial Experience
Executives with proven medtech exits and regulatory approvals drive investor confidence and accelerate market adoption.
04
Global Vision
Strategic advisors and OEM collaborators position TraumaPulse for adoption across North America, Europe, and emerging markets worldwide.

Together, we are building the next gold standard in trauma diagnostics. Our multidisciplinary expertise transforms suspicion into certainty, advancing safer orthopedic traumatology through quantifiable muscular perfusion data.
Meet the People Redefining Trauma Care
Our team is committed to quantifying muscular perfusion, turning clinical uncertainty into actionable data, and scaling AI-enabled ultrasonic innovation globally. From research use only (RUO) applications in orthopedic traumatology trials to broader healthcare screening, we're advancing the future of non-invasive diagnostics.